No Data
No Data
Express News | InMed Pharmaceuticals Inc Files for Offering of 3 Mln Common Shares by Selling Stockholder - SEC Filing
InMed Announces Results of 2024 Annual General Meeting
InMed Enters Into Standby Equity Purchase Agreement
InMed Pharmaceuticals Explores CBN for Skin Disease Treatment
InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System
InMed Pharmaceuticals | 8-K: InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
No Data